Interesting article...I don't think blogs are dead news yet by any means, but John Mack makes some very interesting points about how it is expanding...I use Facebook to expand upon my blog...and myself have not explored Twitter enough to really evaluate and make any substantial statements...but Facebook does offer some extended cov erage for a blog and is an excellent area to create fund raiser sites to generate money for non profits...as has been done by Paul Levy at Beth Israel Deaconess in Boston...for some reason I just don't see the value of knowing where your pharmaceutical rep is by checking in on Twitter just yet...but who knows, maybe that might change some day (grin)...but big companies such as Intel have been using Facebook and others for marketing programs for quite a while now...BD
It's a brave new pharma-marketing world out there, with more and more hospitals and docs barring drug reps and companies turning to electronic detailing to get their messages across. But the online sales pitch has just begun. Networking tools like Facebook and Twitter will soon be de rigeur, replacing blogs as the must-use online tools. Or so says the Pharma Marketing Blog, whose author has been experimenting with a handful of connection-making sites and even Google Maps. The logic is tough to argue with, especially with examples like the one from a Dell exec who says the company's Twitter activity brought in a half-million in new business last year.
Coincidentally, there's an item in an internal-communications trade pub about Pfizer's new RSS feed and its plans for a "FaceBook" site. The article looks at these two initiatives from an internal point of view, but how long can it be before the drugs giant uses similar means to reach its customers?